- Report
- November 2024
- 184 Pages
Global
From €3371EUR$3,545USD£2,834GBP
€3745EUR$3,939USD£3,149GBP
- Report
- February 2025
- 404 Pages
Global
From €5182EUR$5,450USD£4,357GBP
- Report
- September 2023
- 138 Pages
Global
From €4231EUR$4,450USD£3,558GBP
- Report
- August 2023
- 115 Pages
Global
From €4279EUR$4,500USD£3,598GBP
- Report
- January 2024
- 88 Pages
Global
From €3500EUR$3,943USD£3,046GBP
- Report
- January 2024
- 78 Pages
Global
From €3500EUR$3,943USD£3,046GBP
- Report
- March 2025
- 50 Pages
Global
From €2520EUR$2,650USD£2,119GBP
Calcium Lactate is a type of Gastrointestinal Drug used to treat conditions such as hypocalcemia, hyperphosphatemia, and metabolic alkalosis. It is also used to treat calcium deficiencies caused by certain medications, such as diuretics. Calcium Lactate is available in both oral and injectable forms, and is often used in combination with other medications. It is generally well tolerated, with few side effects.
The Calcium Lactate market is driven by the increasing prevalence of gastrointestinal diseases, such as irritable bowel syndrome and Crohn's disease. Additionally, the growing demand for calcium supplements, as well as the increasing awareness of the importance of calcium in the body, are contributing to the growth of the market.
Some of the major companies in the Calcium Lactate market include Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, Sanofi S.A., and Novartis AG. Show Less Read more